Virtu Financial LLC Achilles Therapeutics PLC Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$0.75 - $1.25 $1,399 - $2,332
1,866 Added 8.91%
22,813 $19,000
Q1 2024

May 20, 2024
SELL
$0.82 - $1.57 $15,289 - $29,274
-18,646 Reduced 47.09%
20,947 $26,000
Q4 2023

Feb 26, 2024
BUY
$0.78 - $0.96 $30,882 - $38,009
39,593 New
39,593 $35,000
Q2 2023

Jul 27, 2023
BUY
$0.82 - $1.09 $13,767 - $18,301
16,790 New
16,790 $16,000
Q4 2022

Feb 15, 2023
BUY
$0.79 - $2.39 $24,492 - $74,097
31,003 New
31,003 $28,000

Others Institutions Holding ACHL

# of Institutions
24
Shares Held
24.3M
Call Options Held
0
Put Options Held
0
View Full List

About Achilles Therapeutics plc

ACHL Quotes by TradingView
  • Ticker ACHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,774,000
  • Market Cap $47.3M
  • Description
  • Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...
More about ACHL
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email